ARTG 412631REJURAN i - Dermal tissue reconstructive material, animal-derived
ARTG ID: 412631 · K Bridge Medical Pty Ltd · PharmaResearch Co Ltd · Class III · Started July 05, 2023
Good Name: K Bridge Medical Pty Ltd - REJURAN i - Dermal tissue reconstructive material, animal-derived
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 412631
- Start Date
- July 05, 2023
- Effective Date
- July 05, 2023
- Country
- South Korea
- Address
- 77-19 Gwahakdanji-ro Gangneung-si, Gangwon-do, 25452
REJURAN i, is an injectable gel intended for injection into the mid to deep dermis to promote tissue restoration and reconstruction, and improvement of physical appearance. It is highly versatile and easy to handle and can be used on areas of the face (especially around the eyes, perioral area).
Access comprehensive regulatory information for REJURAN i - Dermal tissue reconstructive material, animal-derived in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 412631 and sponsored by K Bridge Medical Pty Ltd, manufactured by PharmaResearch Co Ltd in South Korea. The device registration started on July 05, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.